Eyebright Medical(688050) Zheng Quan Zhi Xing·2025-05-29 12:29Core Viewpoint - The company announced the cancellation of a portion of the unvested restricted stock from the 2021 incentive plan, totaling 14,688 shares, due to non-compliance with performance criteria by certain employees [6][7][8]. Group 1: Decision Process and Disclosure - The decision to cancel the unvested restricted stock was approved during the second board and supervisory meetings held on May 29, 2025 [6]. - The company followed the necessary decision-making procedures and disclosed relevant information regarding the 2021 restricted stock incentive plan [1][2][3]. Group 2: Specifics of the Canceled Stock - The cancellation affects one individual who no longer meets the criteria for the incentive plan, reducing the number of eligible participants from 82 to 71 [7]. - The total number of restricted stocks canceled is 14,688 shares, which will not significantly impact the company's operations or the continuation of the stock incentive plan [7][8]. Group 3: Opinions from Committees - The Supervisory Board and the Compensation and Assessment Committee both agreed that the cancellation of the unvested restricted stock complies with relevant laws and the company's incentive plan regulations [8][9]. - Legal opinions confirm that the necessary approvals and authorizations for the cancellation have been obtained, ensuring compliance with applicable regulations [8].